Schroder Investment Management Group decreased its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned ...

Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for my updated look at ARWR stock.

Plozasiran, obesity, and the central nervous system are key value drivers fueling growth from its internal development ...

Equities research analysts at Leerink Partnrs cut their FY2026 earnings per share (EPS) estimates for Arrowhead Pharmaceuticals in a report released on Tuesday, March 18th. Leerink Partnrs analyst M.

Track Arrowhead Seperation Enering share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, ...

A lawsuit seeks to prevent Arrowhead from borrowing money for improvements to the campus, even if voters approve an April 1 referendum.

In January, the U.S. Food and Drug Administration accepted Arrowhead Pharmaceuticals’ New Drug Application for investigational plozasiran for familial chylomicronemia syndrome, a severe and rare ...

A boat's history affects it's value—check the history of this 1981 Imp Boats and avoid buying a previously damaged boat. Check for storm damage, accidents, loss, theft, registration history and more.

Wouldnt return my calls. Will never buy from them again. AVOID ARROWHEAD BMW – A COMPLETE NIGHTMARE EXPERIENCE If you value your time, money, and sanity, stay as far away from Arrowhead BMW as ...